Tag: #Type2Diabetes
-
Type 2 Diabetes and Cancer The Hidden Metabolic Link to Colorectal Risk
Introduction The global rise of type 2 diabetes is no longer just an endocrine concern it is increasingly linked to cancer risk and mortality. Emerging research reveals a compelling association between metabolic dysfunction and several malignancies, particularly colorectal cancer. A detailed review published in the Annals of Clinical Endocrinology and Metabolism highlights how hyperinsulinemia, insulin…
-
Hydroxychloroquine vs Teneligliptin in Uncontrolled Type 2 Diabetes A Randomized Trial
Introduction Managing Type 2 diabetes mellitus (T2DM) becomes increasingly complex when patients remain inadequately controlled despite combination therapy with metformin, glimepiride, and insulin. Identifying effective add-on therapies that improve glycemic control while minimizing hypoglycemia is a growing clinical priority. Recent clinical research highlights the comparative role of hydroxychloroquine and teneligliptin as adjunct treatments in insulin-treated…
-
How Regular Exercise Protects Pancreatic β-Cells and Improves Diabetes Outcomes
Introduction Regular physical activity is widely recommended for managing type 2 diabetes, but its direct impact on pancreatic β-cell health has remained a critical research question. A compelling experimental study explores how long-term exercise can protect pancreatic β-cell mass and function in obese diabetic models, offering valuable insights into diabetes prevention and metabolic health. Research…
-
Understanding How RBC Parameters Reflect Glycemic Regulation in Type 2 Diabetes
Introduction Type 2 diabetes continues to rise globally, increasing the importance of reliable biomarkers that help clinicians assess metabolic health and disease progression. This research explores the association between red blood cell (RBC) indicessuch as Packed Cell Volume (PCV), Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin Concentration (MCHC) and Red Cell Distribution Width (RDW)and glycemic…
-
Empagliflozin and Water Retention A Breakthrough in Type 2 Diabetes Management
Introduction: Managing type 2 diabetes mellitus (T2DM) involves addressing multiple metabolic complications, including kidney function and water balance. A recent study published in the Journal of Clinical Nephrology explores how empagliflozin (EMPA), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, influences water retention through prostaglandin E2 (PGE2) responses in the collecting duct (CD). This research sheds light…
Heighten Science Publications Inc. 